|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 4550 Montgomery Avenue |
Address2 | Suite 1100N |
City | Bethesda |
State | MD |
Zip Code | 20814 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 60195-12
|
||||||||
|
6. House ID# 353460000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Mary Dwight, SVP for Policy & CF Community Affairs |
Date | 1/22/2018 6:45:19 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.J. Res. 123: Making further continuing appropriations for fiscal year 2018, and for other purposes; provisions related to funding for the Childrens Health Insurance Program (CHIP), Food and Drug Administration, and the National Institutes of Health
H.R. 601: Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration
H.R. 1370: An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes; provisions related to Childrens Health Insurance Program (CHIP) and pay-as-you-go (PAYGO), National Institutes of Health, and the Food and Drug Administration
H.R. 3268: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration
H.R. 3354: Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018: provisions related to funding for Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration
S. 1603: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daniel |
Cramer |
|
|
|
Mary |
Dwight |
|
|
|
Rachel |
Koren |
|
|
|
Stephanie |
Krenrich |
|
|
|
Sara |
Singleton |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction
H.R. 1628: American Health Care Act of 2017/Better Care Reconciliation Act (Senate); and Graham-Cassidy-Heller-Johnson proposed amendment (S. Amdt. 1030); all provisions
H.R. 3922: CHAMPIONING HEALTHY KIDS Act; all provisions
H.R. 4200: Healthcare Market Certainty and Mandate Relief Act of 2017; all provisions
H.R. 4695: Bipartisan Market Stabilization and Innovation Act of 2017; all provisions
S. 1: An original bill to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction
S. 1827: Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017; all provisions
S. 1835: Lower Premiums Through Reinsurance Act of 2017; all provisions
S. 2052: Health Care Market Certainty and Mandate Relief Act of 2017; all provisions
No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2017; all provisions
General discussions regarding reauthorizing the Childrens Health Insurance Program (CHIP); all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Zoe |
Aldrich |
|
|
|
Daniel |
Cramer |
|
|
|
Mary |
Dwight |
|
|
|
David |
Elin |
|
|
|
Emily |
Kingsland |
|
|
|
Rachel |
Koren |
|
|
|
Stephanie |
Krenrich |
|
|
|
Paydon |
Miller |
|
|
|
Leslie |
Powell |
|
|
|
Sara |
Singleton |
|
|
|
Molly |
Voigt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
H.R. 1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction
H.R. 3922: CHAMPIONING HEALTHY KIDS Act; all provisions
H.R. 4200: Healthcare Market Certainty and Mandate Relief Act of 2017; all provisions
H.R. 4695: Bipartisan Market Stabilization and Innovation Act of 2017; all provisions
S. 1: An original bill to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction
S. 1827: Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017; all provisions
S. 1835: Lower Premiums Through Reinsurance Act of 2017; all provisions
S. 2052: Health Care Market Certainty and Mandate Relief Act of 2017; all provisions
No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2017; all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daniel |
Cramer |
|
|
|
Mary |
Dwight |
|
|
|
David |
Elin |
|
|
|
Emily |
Kingsland |
|
|
|
Rachel |
Koren |
|
|
|
Stephanie |
Krenrich |
|
|
|
Leslie |
Powell |
|
|
|
Sara |
Singleton |
|
|
|
Molly |
Voigt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.J. Res. 123: Making further continuing appropriations for fiscal year 2018, and for other purposes; provisions related to funding for the National Institutes of Health, Childrens Health Insurance Program, and the Food and Drug Administration
H.R. 601: Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration
H.R. 1370: An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes; provisions related to Childrens Health Insurance Program (CHIP) and pay-as-you-go (PAYGO), National Institutes of Health, and the Food and Drug Administration
H.R. 3354: Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018: provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daniel |
Cramer |
|
|
|
Mary |
Dwight |
|
|
|
Rachel |
Koren |
|
|
|
Stephanie |
Krenrich |
|
|
|
Sara |
Singleton |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2017; all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daniel |
Cramer |
|
|
|
Mary |
Dwight |
|
|
|
David |
Elin |
|
|
|
Rachel |
Koren |
|
|
|
Stephanie |
Krenrich |
|
|
|
Leslie |
Powell |
|
|
|
Sara |
Singleton |
|
|
|
Molly |
Voigt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction
S. 1: An original bill to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Zoe |
Aldrich |
|
|
|
Daniel |
Cramer |
|
|
|
Mary |
Dwight |
|
|
|
David |
Elin |
|
|
|
Rachel |
Koren |
|
|
|
Stephanie |
Krenrich |
|
|
|
Paydon |
Miller |
|
|
|
Leslie |
Powell |
|
|
|
Sara |
Singleton |
|
|
|
Molly |
Voigt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |